QNCX Cash-Secured Put Strategy
QNCX (Quince Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Quince Therapeutics, Inc. (QNCX) operates as a biopharmaceutical firm dedicated to developing targeted treatments for debilitating and rare diseases. A cornerstone of their innovation is an extensive bone-targeting drug delivery platform, engineered to accurately transport diverse therapeutic agents, such as small molecules, peptides, and large molecules, directly to affected bone areas like fractures and disease sites. Leading their pipeline is NOV004, an anabolic peptide meticulously designed to pinpoint and accumulate its therapeutic action precisely at bone fracture locations. The company, previously known as Cortexyme, Inc., officially rebranded as Quince Therapeutics, Inc. in August 2022. Established in 2012, Quince Therapeutics is headquartered in South San Francisco, California.
QNCX (Quince Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $5.3M, a beta of 1.37 versus the broader market, a 52-week range of 0.79-45.5, average daily share volume of 4.9M, a public-listing history dating back to 2019, approximately 36 full-time employees. These structural characteristics shape how QNCX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.37 indicates QNCX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a cash-secured put on QNCX?
A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.
Current QNCX snapshot
As of June 30, 2026, spot at $19.24, ATM IV 39.80%, IV rank 3.77%, expected move 11.41%. The cash-secured put on QNCX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this cash-secured put structure on QNCX specifically: QNCX IV at 39.80% is on the cheap side of its 1-year range, which means a premium-selling QNCX cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 11.41% (roughly $2.20 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated QNCX expiries trade a higher absolute premium for lower per-day decay. Position sizing on QNCX should anchor to the underlying notional of $19.24 per share and to the trader's directional view on QNCX stock.
QNCX cash-secured put setup
The QNCX cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With QNCX near $19.24, the first option leg uses a $18.28 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed QNCX chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 QNCX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Put | $18.28 | N/A |
QNCX cash-secured put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.
QNCX cash-secured put payoff curve
Modeled P&L at expiration across a range of underlying prices for the cash-secured put on QNCX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use cash-secured put on QNCX
Cash-secured puts on QNCX earn premium while a trader waits to acquire QNCX stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning QNCX.
QNCX thesis for this cash-secured put
The market-implied 1-standard-deviation range for QNCX extends from approximately $17.04 on the downside to $21.44 on the upside. A QNCX cash-secured put lets a trader earn premium while waiting to acquire QNCX at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current QNCX IV rank near 3.77% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on QNCX at 39.80%. As a Healthcare name, QNCX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to QNCX-specific events.
QNCX cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. QNCX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move QNCX alongside the broader basket even when QNCX-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on QNCX carry tail risk when realized volatility exceeds the implied move; review historical QNCX earnings reactions and macro stress periods before sizing. Always rebuild the position from current QNCX chain quotes before placing a trade.
Frequently asked questions
- What is a cash-secured put on QNCX?
- A cash-secured put on QNCX is the cash-secured put strategy applied to QNCX (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With QNCX stock trading near $19.24, the strikes shown on this page are snapped to the nearest listed QNCX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are QNCX cash-secured put max profit and max loss calculated?
- Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the QNCX cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 39.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a QNCX cash-secured put?
- The breakeven for the QNCX cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current QNCX market-implied 1-standard-deviation expected move is approximately 11.41%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a cash-secured put on QNCX?
- Cash-secured puts on QNCX earn premium while a trader waits to acquire QNCX stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning QNCX.
- How does current QNCX implied volatility affect this cash-secured put?
- QNCX ATM IV is at 39.80% with IV rank near 3.77%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.